CMIC, Inc. is a US-based leading CRO and a provider specialized in bioanalytical services in support of measurement of in vivo sample drug concentrations and analysis of biomarkers using cutting-edge capabilities. Recently, drug development has been progressing due to globalization and the needs of simultaneous collaboration between Japan and the U.S. are increasing in bioanalysis services. The company can provide services in Japan and the U.S. simultaneously by cooperation with CMIC Pharma Science which provides support services of non-clinical research and bioanalysis in Japan.